Lung cancer: active therapeutic targeting and inhalational nanoproduct design

Volume: 15, Issue: 12, Pages: 1223 - 1247
Published: Nov 20, 2018
Abstract
Pulmonary drug delivery is organ-specific and benefits local drug action for lung cancer. The use of nanotechnology and targeting ligand enables cellular-specific drug action. Combination approaches increase therapeutic efficacy and reduce adverse effects of cancer chemotherapeutics that have narrow therapeutic index window and high cytotoxicity levels. The current progress of inhaled cancer chemotherapeutics has not been examined with respect...
Paper Details
Title
Lung cancer: active therapeutic targeting and inhalational nanoproduct design
Published Date
Nov 20, 2018
Volume
15
Issue
12
Pages
1223 - 1247
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.